Timothy Beck, MD
Foot and Ankle Surgery · Tyler, TXNPI 1528056645
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Arthrex at 51.0% of the total. Reporting peaked in 2019 at $2,645 and has fallen 96.7% since, to $86 in 2025. That places this record below the midpoint for foot and ankle surgery clinicians in TX, where the typical reported total is $3,901.
Across 32 payments — averaging $93.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Pylant Medical$733
- Stryker$294
- Wound Management Technologies, Inc$113
- Medtronic$100
- Bioventus LLC$99
- plus $127 from 3 others
What the payments were for
- Travel & lodging$97433%
- Food & beverage$1,13538%
- Education$88129%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $1,523 |
| Pylant Medical | 7 | $733 |
| Stryker(2 entities) | 6 | $294 |
| Wound Management Technologies, Inc | 1 | $113 |
| Medtronic | 1 | $100 |
| Bioventus LLC | 5 | $99 |
| Osteocentric Technologies, Inc. | 1 | $98 |
| Avanos Medical | 1 | $18 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$122
- CellerateRx$113
How this compares
$2,989 in reported general payments places this provider in the 40th percentile of 684 foot and ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 81 | $864 |
| Celecoxib | 23 | $443 |
| Cephalexin | 104 | $403 |
| Gabapentin | 36 | $281 |
| Tramadol Hcl | 34 | $109 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Tyler
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.